Search research articles
Contact Us
Filters
Showing results (231-240 of 420) with videos related to
Page
of 42
Sort By:
International Journal of Antimicrobial Agents
|
May 9, 2026
Multidrug-Resistant Enterobacterales in United States Hospitals: Frequency and Susceptibility to Newer β-Lactamase Inhibitor Combinations (2020-2024)
Helio S Sader, Rodrigo E Mendes, John H Kimbrough, et al.
Antibiotics (Basel, Switzerland)
|
April 27, 2026
Antimicrobial Susceptibility of <i>Pseudomonas aeruginosa</i> from Elderly Patients in Intensive Care Units of United States Medical Centers (2021-2025)
Helio S Sader, Rodrigo E Mendes, Timothy B Doyle, et al.
Antimicrobial Agents and Chemotherapy
|
November 22, 2021
Activity of Oritavancin against Gram-Positive Pathogens Causing Bloodstream Infections in the United States over 10 Years: Focus on Drug-Resistant Enterococcal Subsets (2010-2019)
Cecilia G Carvalhaes, Helio S Sader, Jennifer M Streit, et al.
Microbial Drug Resistance (Larchmont, N.Y.)
|
February 21, 2009
Dissemination of a bla(VIM-2)-carrying integron among Enterobacteriaceae species in Mexico: report from the SENTRY Antimicrobial Surveillance Program
Rayo Morfin-Otero, Eduardo Rodriguez-Noriega, Lalitagauri M Deshpande, et al.
Diagnostic Microbiology and Infectious Disease
|
October 21, 2021
Antimicrobial susceptibility of Gram-negative bacteria from intensive care unit and non-intensive care unit patients from United States hospitals (2018-2020)
Helio S Sader, Rodrigo E Mendes, Jennifer M Streit, et al.
International Journal of Antimicrobial Agents
|
November 16, 2010
Antimicrobial characterisation of solithromycin (CEM-101), a novel fluoroketolide: activity against staphylococci and enterococci
Shannon D Putnam, Helio S Sader, David J Farrell, et al.
The Journal of Infection
|
April 6, 2010
The in vitro evaluation of tigecycline tested against pathogens isolated in eight countries in the Asia-Western Pacific region (2008)
David J Farrell, John D Turnidge, Jan Bell, et al.
The Journal of Antimicrobial Chemotherapy
|
August 30, 2021
Increasing frequency of OXA-48-producing Enterobacterales worldwide and activity of ceftazidime/avibactam, meropenem/vaborbactam and comparators against these isolates
Mariana Castanheira, Timothy B Doyle, Timothy D Collingsworth, et al.
Journal of Clinical Microbiology
|
July 21, 2012
Disk diffusion and MIC quality control ranges for BC-3205 and BC-3781, two novel pleuromutilin antibiotics
James E Ross, Helio S Sader, Zrinka Ivezic-Schoenfeld, et al.
Antimicrobial Agents and Chemotherapy
|
July 27, 2004
Omiganan pentahydrochloride (MBI 226), a topical 12-amino-acid cationic peptide: spectrum of antimicrobial activity and measurements of bactericidal activity
Helio S Sader, Kelley A Fedler, Robert P Rennie, et al.
Page
of 42
Search research articles
Search
Showing results (231-240 of 420) with videos related to
Sort By:
Page
of 42
International Journal of Antimicrobial Agents
|
May 9, 2026
Multidrug-Resistant Enterobacterales in United States Hospitals: Frequency and Susceptibility to Newer β-Lactamase Inhibitor Combinations (2020-2024)
Helio S Sader, Rodrigo E Mendes, John H Kimbrough, et al.
Antibiotics (Basel, Switzerland)
|
April 27, 2026
Antimicrobial Susceptibility of <i>Pseudomonas aeruginosa</i> from Elderly Patients in Intensive Care Units of United States Medical Centers (2021-2025)
Helio S Sader, Rodrigo E Mendes, Timothy B Doyle, et al.
Antimicrobial Agents and Chemotherapy
|
November 22, 2021
Activity of Oritavancin against Gram-Positive Pathogens Causing Bloodstream Infections in the United States over 10 Years: Focus on Drug-Resistant Enterococcal Subsets (2010-2019)
Cecilia G Carvalhaes, Helio S Sader, Jennifer M Streit, et al.
Microbial Drug Resistance (Larchmont, N.Y.)
|
February 21, 2009
Dissemination of a bla(VIM-2)-carrying integron among Enterobacteriaceae species in Mexico: report from the SENTRY Antimicrobial Surveillance Program
Rayo Morfin-Otero, Eduardo Rodriguez-Noriega, Lalitagauri M Deshpande, et al.
Diagnostic Microbiology and Infectious Disease
|
October 21, 2021
Antimicrobial susceptibility of Gram-negative bacteria from intensive care unit and non-intensive care unit patients from United States hospitals (2018-2020)
Helio S Sader, Rodrigo E Mendes, Jennifer M Streit, et al.
International Journal of Antimicrobial Agents
|
November 16, 2010
Antimicrobial characterisation of solithromycin (CEM-101), a novel fluoroketolide: activity against staphylococci and enterococci
Shannon D Putnam, Helio S Sader, David J Farrell, et al.
The Journal of Infection
|
April 6, 2010
The in vitro evaluation of tigecycline tested against pathogens isolated in eight countries in the Asia-Western Pacific region (2008)
David J Farrell, John D Turnidge, Jan Bell, et al.
The Journal of Antimicrobial Chemotherapy
|
August 30, 2021
Increasing frequency of OXA-48-producing Enterobacterales worldwide and activity of ceftazidime/avibactam, meropenem/vaborbactam and comparators against these isolates
Mariana Castanheira, Timothy B Doyle, Timothy D Collingsworth, et al.
Journal of Clinical Microbiology
|
July 21, 2012
Disk diffusion and MIC quality control ranges for BC-3205 and BC-3781, two novel pleuromutilin antibiotics
James E Ross, Helio S Sader, Zrinka Ivezic-Schoenfeld, et al.
Antimicrobial Agents and Chemotherapy
|
July 27, 2004
Omiganan pentahydrochloride (MBI 226), a topical 12-amino-acid cationic peptide: spectrum of antimicrobial activity and measurements of bactericidal activity
Helio S Sader, Kelley A Fedler, Robert P Rennie, et al.
Page
of 42